-
Innovation Ranking
NewInnovation Ranking – Personalis Inc
Personalis Inc (Personalis) provides genomic sequencing and analytics solutions for developing vaccines to treat cancers. The company develops end-to-end solutions for immuno-oncology through its Immunoid NeXT Platform. It also helps in identifying therapies and clinical trials to treat cancer patients using NeXT Dx Test, a genomic testing solution. Personalis also offers next-generation sequencing (NGS) assays for the generation and interpretation of molecular data. The company uses accuracy and content-enhanced technology for developing its products. It partners with biopharmaceutical companies for...
-
Company Insights
Innovation and Patenting activity of Personalis Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Personalis Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Company Profile
Personalis Inc – Company Profile
Personalis Inc (Personalis) provides genomic sequencing and analytics solutions for developing vaccines to treat cancers. The company develops end-to-end solutions for immuno-oncology through its Immunoid NeXT Platform. It also helps in identifying therapies and clinical trials to treat cancer patients using NeXT Dx Test, a genomic testing solution. Personalis also offers next-generation sequencing (NGS) assays for the generation and interpretation of molecular data. The company uses accuracy and content-enhanced technology for developing its products. It partners with biopharmaceutical companies for...
Add to Basket -
Sector Analysis
United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others
GlobalData’s “United States In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on: • Annualized market...